BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11284261)

  • 1. [Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome].
    Di Rienzo L; Artuso A; Cerqua N
    Acta Otorhinolaryngol Ital; 2000 Oct; 20(5):336-42. PubMed ID: 11284261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of ASS-Associated Polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist - a prospective drug study on its antiinflammatory effects].
    Grundmann T; Töpfner M
    Laryngorhinootologie; 2001 Oct; 80(10):576-82. PubMed ID: 11602930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
    J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of montelukast on quality of life in subjects with nasal polyposis accompanying bronchial asthma.
    Yazıcı ZM; Sayın I; Bozkurt E; Kayhan FT
    Kulak Burun Bogaz Ihtis Derg; 2011; 21(4):210-4. PubMed ID: 21762051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps.
    Vuralkan E; Saka C; Akin I; Hucumenoglu S; Unal BU; Kuran G; Ocal B
    Ther Adv Respir Dis; 2012 Feb; 6(1):5-10. PubMed ID: 22042749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of leukotriene inhibitors in the postoperative management of nasal polyps.
    Mostafa BE; Abdel Hay H; Mohammed HE; Yamani M
    ORL J Otorhinolaryngol Relat Spec; 2005; 67(3):148-53. PubMed ID: 15925911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nasal polyps is not a homogenous pathology].
    Arcimowicz M; Balcerzak J; Samoliński BK
    Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of nasal polyps after surgical treatment.
    Jäntti-Alanko S; Holopainen E; Malmberg H
    Rhinol Suppl; 1989; 8():59-64. PubMed ID: 2772495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease].
    Almeida Arvizu V; Guidos Fogelbach G; Sánchez Sánchez B; Vásquez Nava F; Matta Campos J; López Medina L; Rivera Pérez J; Mejía Covarrubias F; Montero Mora P
    Rev Alerg Mex; 2005; 52(4):151-8. PubMed ID: 16268183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
    Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma.
    Jankowski R; Moneret-Vautrin DA; Goetz R; Wayoff M
    Rhinology; 1992 Dec; 30(4):249-58. PubMed ID: 1470826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
    Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
    Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
    Saengpanich S; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics.
    Stevenson DD; Simon RA; Mathison DA; Christiansen SC
    Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):477-82. PubMed ID: 11152169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis.
    Stewart RA; Ram B; Hamilton G; Weiner J; Kane KJ
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):682-7. PubMed ID: 18984264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in vulvar vestibulitis with montelukast.
    Kamdar N; Fisher L; MacNeill C
    J Reprod Med; 2007 Oct; 52(10):912-6. PubMed ID: 17977165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.